Skip to content

Maan ZREIN

  • PhD
  • CEO/CSO
  • INFYNITY BIOMARKERS
  • 13h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 431CitationsNumber of citations received by Maan's publications. Updated daily.

About

Designing the most advanced IVD methods by multiplexing serology parameters

Recent publications

  • A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients

    • Zrein M
    • Granjon E
    • Gueyffier L
    • et al.
    N/AReaders
    12Citations
  • A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas' disease

    • Oelemann W
    • Vanderborght B
    • Verissimo Da Costa G
    • et al.
    N/AReaders
    23Citations

Professional experience

CEO/CSO

INFYNITY BIOMARKERS

December 2009 - Present

Co-authors (91)

Other IDs